An accumulating body of evidence suggests that intramyocellular accumulation of lipid metabolites directly leads to insulin resistance, via defects in insulin signaling and reduced insulin-stimulated glucose-transport activity (Shulman, 2014; Samuel and Shulman, 2016; Petersen and Shulman, 2018). This evidence concerns the gene INS and Insulin resistance.